89 related articles for article (PubMed ID: 26178778)
1. Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia.
Shim GH; Kim HS; Kim ES; Lee KY; Kim EK; Choi JH
Free Radic Res; 2015; 49(11):1362-70. PubMed ID: 26178778
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury.
Nowak-Machen M; Lange M; Exley M; Wu S; Usheva A; Robson SC
Purinergic Signal; 2015 Dec; 11(4):455-61. PubMed ID: 26306905
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin/Lpar3 signaling regulates Kupffer's vesicle formation and left-right asymmetry in zebrafish.
Lai SL; Yao WL; Tsao KC; Houben AJ; Albers HM; Ovaa H; Moolenaar WH; Lee SJ
Development; 2012 Dec; 139(23):4439-48. PubMed ID: 23095890
[TBL] [Abstract][Full Text] [Related]
4. The significance of the altered expression of lysophosphatidic acid receptors, autotaxin and phospholipase A2 as the potential biomarkers in type 1 endometrial cancer biology.
Wasniewski T; Woclawek-Potocka I; Boruszewska D; Kowalczyk-Zieba I; Sinderewicz E; Grycmacher K
Oncol Rep; 2015 Nov; 34(5):2760-7. PubMed ID: 26327335
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
6. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma.
Popnikolov NK; Dalwadi BH; Thomas JD; Johannes GJ; Imagawa WT
Tumour Biol; 2012 Dec; 33(6):2237-43. PubMed ID: 22922883
[TBL] [Abstract][Full Text] [Related]
7. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
[TBL] [Abstract][Full Text] [Related]
8. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
9. Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats.
Chen X; Walther FJ; van Boxtel R; Laghmani EH; Sengers RM; Folkerts G; DeRuiter MC; Cuppen E; Wagenaar GT
Acta Physiol (Oxf); 2016 Mar; 216(3):358-75. PubMed ID: 26495902
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell proliferation by insulin-like growth factor 1 in hyperoxia-exposed neonatal rat lung.
Chetty A; Nielsen HC
Mol Genet Metab; 2002 Mar; 75(3):265-75. PubMed ID: 11914039
[TBL] [Abstract][Full Text] [Related]
11. Adult Lysophosphatidic Acid Receptor 1-Deficient Rats with Hyperoxia-Induced Neonatal Chronic Lung Disease Are Protected against Lipopolysaccharide-Induced Acute Lung Injury.
Chen X; Walther FJ; Laghmani EH; Hoogeboom AM; Hogen-Esch AC; van Ark I; Folkerts G; Wagenaar GT
Front Physiol; 2017; 8():155. PubMed ID: 28382003
[No Abstract] [Full Text] [Related]
12. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
13. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
14. Which bovine endometrial cells are the source of and target for lysophosphatidic acid?
Boruszewska D; Kowalczyk-Zieba I; Piotrowska-Tomala K; Saulnier-Blache JS; Acosta T; Skarzynski DJ; Woclawek-Potocka I
Reprod Biol; 2013 Mar; 13(1):100-3. PubMed ID: 23522079
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin-Lysophosphatidic Acid Axis Acts Downstream of Apoprotein B Lipoproteins in Endothelial Cells.
Gibbs-Bar L; Tempelhof H; Ben-Hamo R; Ely Y; Brandis A; Hofi R; Almog G; Braun T; Feldmesser E; Efroni S; Yaniv K
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2058-67. PubMed ID: 27562917
[TBL] [Abstract][Full Text] [Related]
16. The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.
Kim SJ; Moon HG; Park GY
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158641. PubMed ID: 32004685
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.
Cheng HY; Dong A; Panchatcharam M; Mueller P; Yang F; Li Z; Mills G; Chun J; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):24-32. PubMed ID: 22015657
[TBL] [Abstract][Full Text] [Related]
18. Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.
Jethwa SA; Leah EJ; Zhang Q; Bright NA; Oxley D; Bootman MD; Rudge SA; Wakelam MJ
J Cell Sci; 2016 Oct; 129(20):3948-3957. PubMed ID: 27557622
[TBL] [Abstract][Full Text] [Related]
19. Relative expression and regulation by short-term fasting of lysophosphatidic acid receptors and autotaxin in white and brown adipose tissue depots.
M'Hiri I; Diaguarachchige De Silva KH; Duncan RE
Lipids; 2020 May; 55(3):279-284. PubMed ID: 32069377
[TBL] [Abstract][Full Text] [Related]
20. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung.
Lizotte PP; Hanford LE; Enghild JJ; Nozik-Grayck E; Giles BL; Oury TD
BMC Dev Biol; 2007 Mar; 7():15. PubMed ID: 17343756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
